Injuries prompt recall of Medtronic insulin sets:
This article was originally published in Clinica
Medtronic is recalling its Quick-set Plus insulin infusion sets for diabetics in the US after a number of serious injuries and hospitalisations. Bending of the cannula and accidental disconnection at the insertion site causing interruption to the flow of insulin have been reported. The recall has been defined as class I by the FDA, meaning there is "a reasonable probability that the use of the product will cause serious adverse health consequences or death". In March, the company gave customers a tips guide for using the device, and offered replacement sets on request, following increased number of complaints. Medtronic has stopped selling Quick-set Plus sets.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.